Thomas Steyer’s Alder Biopharmaceuticals ALDR Stock Holding History

Thomas Steyer’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,165,000	Closed	-$78.6M	–	130
2019 Q3	$78.6M	Buy	+4,165,000	New	+$47.6M	0.59%	38
2014 Q3	–	Sell	-100,000	Closed	-$2.01M	–	100
2014 Q2	$2.01M	Buy	+100,000	New	+$1.41M	0.03%	87

Thomas Steyer's ALDR Position: Q4 2019 in Review

Thomas Steyer sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 4,165,000 shares — an estimated $78.6M sold.

Thomas Steyer first reported a position in ALDR in Q2 2014 and held it in 2 quarters. The position peaked at $78.6M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Thomas Steyer reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Thomas Steyer sold 4,165,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $78.6M.
Thomas Steyer first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 2 quarters.
Thomas Steyer's Alder Biopharmaceuticals position peaked at $78.6M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Farallon Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.